BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38369188)

  • 1. Quantitative Multiplexed Analysis of Indoleamine 2,3-Dioxygenase (IDO) and Arginase-1 (ARG1) Expression and Myeloid Cell Infiltration in Colorectal Cancer.
    Elomaa H; Härkönen J; Väyrynen SA; Ahtiainen M; Ogino S; Nowak JA; Lau MC; Helminen O; Wirta EV; Seppälä TT; Böhm J; Mecklin JP; Kuopio T; Väyrynen JP
    Mod Pathol; 2024 Apr; 37(4):100450. PubMed ID: 38369188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironment.
    Väyrynen JP; Haruki K; Väyrynen SA; Lau MC; Dias Costa A; Borowsky J; Zhao M; Ugai T; Kishikawa J; Akimoto N; Zhong R; Shi S; Chang TW; Fujiyoshi K; Arima K; Twombly TS; Da Silva A; Song M; Wu K; Zhang X; Chan AT; Nishihara R; Fuchs CS; Meyerhardt JA; Giannakis M; Ogino S; Nowak JA
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
    Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
    Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.
    Takamatsu M; Hirata A; Ohtaki H; Hoshi M; Ando T; Ito H; Hatano Y; Tomita H; Kuno T; Saito K; Seishima M; Hara A
    Cancer Sci; 2015 Aug; 106(8):1008-15. PubMed ID: 26033215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
    Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
    Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
    Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
    J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells.
    Mondanelli G; Bianchi R; Pallotta MT; Orabona C; Albini E; Iacono A; Belladonna ML; Vacca C; Fallarino F; Macchiarulo A; Ugel S; Bronte V; Gevi F; Zolla L; Verhaar A; Peppelenbosch M; Mazza EMC; Bicciato S; Laouar Y; Santambrogio L; Puccetti P; Volpi C; Grohmann U
    Immunity; 2017 Feb; 46(2):233-244. PubMed ID: 28214225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of indoleamine 2,3-dioxygenase in acute myeloid leukemia.
    Sobash PT; Kolhe R; Karim NA; Guddati AK; Jillella A; Kota V
    Future Oncol; 2020 Dec; 16(36):3085-3094. PubMed ID: 32976029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients.
    Zhou QH; Han H; Lu JB; Liu TY; Huang KB; Deng CZ; Li ZS; Chen JP; Yao K; Qin ZK; Liu ZW; Li YH; Guo SJ; Ye YL; Zhou FJ; Liu RY
    Cancer Commun (Lond); 2020 Jan; 40(1):3-15. PubMed ID: 32125093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
    Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
    Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma.
    Ben-Haj-Ayed A; Moussa A; Ghedira R; Gabbouj S; Miled S; Bouzid N; Tebra-Mrad S; Bouaouina N; Chouchane L; Zakhama A; Hassen E
    Immunol Lett; 2016 Jan; 169():23-32. PubMed ID: 26608400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis significance of indoleamine 2, 3-dioxygenase, programmed death ligand-1 and tumor-infiltrating immune cells in microenvironment of breast cancer.
    Wei L; Wu N; Wei F; Li F; Zhang Y; Liu J; Ren X
    Int Immunopharmacol; 2020 Jul; 84():106506. PubMed ID: 32330866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine 2, 3-Dioxygenase: A Professional Immunomodulator and Its Potential Functions in Immune Related Diseases.
    Heidari F; Ramezani A; Erfani N; Razmkhah M
    Int Rev Immunol; 2022; 41(3):346-363. PubMed ID: 33118843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer.
    Zhao Y; Wei L; Liu J; Li F
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):77-93. PubMed ID: 31844921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
    Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
    Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and prognostic relevance of indoleamine 2,3-dioxygenase in tongue squamous cell carcinoma.
    Seppälä M; Halme E; Tiilikainen L; Luukkainen A; Laranne J; Rautiainen M; Huhtala H; Paavonen T; Toppila-Salmi S
    Acta Otolaryngol; 2016 Jul; 136(7):729-35. PubMed ID: 26982018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
    Schafer CC; Wang Y; Hough KP; Sawant A; Grant SC; Thannickal VJ; Zmijewski J; Ponnazhagan S; Deshane JS
    Oncotarget; 2016 Nov; 7(46):75407-75424. PubMed ID: 27705910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
    Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
    Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer.
    Astigiano S; Morandi B; Costa R; Mastracci L; D'Agostino A; Ratto GB; Melioli G; Frumento G
    Neoplasia; 2005 Apr; 7(4):390-6. PubMed ID: 15967116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD15
    Miyoshi K; Sato E; Katsumata K; Fukushima G; Udo R; Nishimura E; Tago T; Kasahara K; Mazaki J; Enomoto M; Ishizaki T; Nagakawa Y; Tsuchida A
    Anticancer Res; 2022 Jan; 42(1):459-470. PubMed ID: 34969756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.